Antidiabetic Activity of Plumeria Alba Linn (Apocynaceae) Root Extract and Fractions in Streptozotocin-Induced Diabetic Rats
Abstract
Purpose: To investigate the effect of total hydroalcohol root extract of Plumeria alba (Apocynaceae) and its active fraction on diabetes in rats.
Methods: The effect of total hydroalcohol extract at 250 mg/kg and different fractions was evaluated on oral glucose tolerance test (OGTT) in mice. The effect of the active fractions on OGTT was measured on a model of diabetic rats (fructose-enriched fat diet and streptozotocin-induced).
Results: The results show that the total extract (250 mg/kg), ethyl acetate fraction and supernatant fraction (obtained after centrifugation of total extract) at a dose of 100 mg/kg significantly (p < 0.01) reduced hyperglycemia induced by glucose overload in mice. Fructose-enriched fat diet increased blood cholesterol, triglycerides and high density lipoprotein (HDL) levels in hyperlipidemic untreated rats compared to normal control rats. Administration of total extract (250 mg/kg/day) and supernatant fraction of P. alba (100 mg/kg/day) during 14 days significantly reduced lipid parameters (total cholesterol, p < 0.001; triglycerides, p < 0.01; HDL, p < 0.05). Analysis of oxidative stress markers shows that the supernatant fraction and total extract significantly increased serum glutathione level (p < 0.01) but significantly lowered malondialdehyde (MDA) concentration in liver (p < 0.05).
Conclusion: These results suggest that the total extract and fractions of P. alba exhibit significant antidiabetic and hypolipidemic properties in streptozotocin induced diabetic animals. The supernatant fraction (which is free of organic solvent) was the most biologically active
Keywords: Diabetes, Hyperlipidermia, Plumeria alba, Fructose-enriched fat diet, Oxidative stress markers, Streptozotocin
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
